Back to MREO
MARSHALL WACE, LLP MREO Position History
Mereo BioPharma Group plc • Healthcare
Quarters held
12
Latest value
$10K
Q3 2026
Peak value
$4.2M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $34K |
| Q2 2024 | $4.1M |
| Q3 2024 | $4.2M |
| Q4 2024 | $3M |
| Q1 2025 | $1.7M |
| Q2 2025 | $2.1M |
| Q3 2025 | $1.6M |
| Q1 2026 | $26K |
| Q1 2026 | $200K |
| Q2 2026 | $11K |
| Q2 2026 | $47K |
| Q3 2026 | $10K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10K | 24.0K | — | — |
| Q2 2026 | $47K | 147.0K | — | — |
| Q2 2026 | $11K | 32.9K | — | — |
| Q1 2026 | $200K | 607.1K | — | — |
| Q1 2026 | $26K | 79.9K | — | — |
| Q3 2025 | $1.6M | 767.7K | — | — |
| Q2 2025 | $2.1M | 767.7K | — | — |
| Q1 2025 | $1.7M | 767.7K | — | — |
| Q4 2024 | $3M | 866.3K | — | — |
| Q3 2024 | $4.2M | 1.03M | — | — |
| Q2 2024 | $4.1M | 1.14M | — | — |
| Q4 2023 | $34K | 14.9K | — | — |
Other funds holding MREO
$12.4M
$11.4M
$9.6M